Trials / Unknown
UnknownNCT05153928
Management of Uterine Leiomyomata and Adenomyosis
Management of Uterine Leiomyomata and Adenomyosis : Role of Hysteroscopy in Diagnosis and Norethisterone in the Treatment
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Ahmed Ali Mahmoud · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
1. to determine the role of hysteroscopy and guided biopsy to differentiate between submucosal fibroids and adenomyosis confirmed by histopathological examination 2. to evaluate the efficacy of norethisterone in the treatment of symptomatic adenomyosis and leiomyoma
Detailed description
The aim of the present study is: 1. to determine the role of hysteroscopy and guided biopsy to differentiate between submucosal fibroids and adenomyosis confirmed by histopathological examination 2. to evaluate the efficacy of norethisterone in the treatment of symptomatic adenomyosis and leiomyoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Norethisterone acetate | Norethisterone acetate for 5 months |
Timeline
- Start date
- 2021-04-10
- Primary completion
- 2021-11-25
- Completion
- 2021-12-25
- First posted
- 2021-12-10
- Last updated
- 2021-12-10
Locations
2 sites across 1 country: Egypt
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05153928. Inclusion in this directory is not an endorsement.